Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/151479
Registo completo
Campo DCValorIdioma
dc.creatorPinello, K
dc.creatorAmorim, I
dc.creatorPires, I
dc.creatorCanadas Sousa, A
dc.creatorCatarino, J
dc.creatorFaisca, P
dc.creatorBranco, S
dc.creatorPeleteiro, MC
dc.creatorSilva, D
dc.creatorSevero, M
dc.creatorNiza Ribeiro, J
dc.date.accessioned2023-08-02T09:06:09Z-
dc.date.available2023-08-02T09:06:09Z-
dc.date.issued2022
dc.identifier.issn2306-7381
dc.identifier.urihttps://hdl.handle.net/10216/151479-
dc.description.abstractAnalysis of canine and feline tumor malignancy data can help clinicians identify high-risk patients and make more accurate decisions. Based on a sample of 16,272 cancer records, including 3266 cats and 13,006 dogs, collected from January 2019 to December 2021 in the Vet-OncoNet Network database, this study aimed to compare the tumor malignancy profile between cats and dogs, considering animal-related factors (sex, age, and breed), topography, and geographic location using a mixed-effects logistic regression model. Cats had a higher proportion of malignant tumors (78.7%) than dogs (46.2%), and the malignancy profile was very different regarding tumors’ topographies. The mean age of malignant tumors occurred eight months later than benign ones (9.1, SD = 3.4; 9.8, SD = 3.2), in general. Species (OR = 3.96, 95%CI 3.57: 4.39) and topography (MOR = 4.10) were the two most important determinants of malignancy risk. Female dogs had a higher risk than male dogs (OR = 1.19, 95%CI 1.08: 1.31), which does not appear to be the case in cats (OR = 0.98, 95%CI 0.77: 1.23). Breed contributed significantly to differences in malignancy risk in dogs (MOR = 1.56), particularly in pit bulls and boxers. District of residence was not so relevant in predicting malignancy risk (MOR = 1.14). In both species, the risk of malignancy increased by approximately 20% every three years. It could be hypothesized that species differences in genetic structure may contribute to tumor malignancy. © 2022 by the authors.
dc.description.sponsorshipFunding text 1: We gratefully acknowledge Henrique Cyrne Carvalho, and the Board of the School of Medicine and Biomedical Sciences, ICBAS, University of Porto. The participation of IP was funded by project UIDB/CVT/00772/2020 supported by the Portuguese Foundation for Science and Technology (FCT). ; Funding text 2: This study was financed through the financial support of School of Medicine and Biomedical Sciences, ICBAS, University of Porto.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofVet Sci. 2022 Sep 28;9(10):535. doi: 10.3390/vetsci9100535.
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectcancer; cat; dog; malignancy; veterinary oncology
dc.titleVet-OncoNet: Malignancy Analysis of Neoplasms in Dogs and Cats
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.3390/vetsci9100535
dc.relation.publisherversionhttps://www.mdpi.com/2306-7381/9/10/535
Aparece nas coleções:ISPUP - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
pinello-amorim-vs-2022.pdf2.63 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons